Article
Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and non-human primates
2023-08-23
Abstract excerpt
Pathogenic mutations in the OTOF gene cause autosomal recessive hearing loss 9 (DFNB9), one of the most common forms of auditory neuropathy. There is no biological treatment for DFNB9. Here, we designed an OTOF gene therapy agent by dual AAV1 carrying human OTOF coding sequences with the expression driven by the hair cell-specific promoter Myo15 , AAV1-hOTOF. To develop a clinical application of AAV1-hOTOF gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 00efe186-21b6-5f44-b58d-a6e50d989921
- DOI
- 10.1101/2023.08.22.554252
